BL-8040 + Placebo

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 19/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)

Conditions

Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)

Trial Timeline

Aug 1, 2014 → Jul 1, 2015

NCT ID

NCT02073019

About BL-8040 + Placebo

BL-8040 + Placebo is a phase 1 stage product being developed by BioLineRx for Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB). The current trial status is completed. This product is registered under clinical trial identifier NCT02073019. Target conditions include Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB).

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02073019	Phase 1	Completed	Aug 1, 2014	Jul 1, 2015	Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)